MyPurMist

Concord, United States Founded: 2001 • Age: 25 yrs
Medical humidification devices are developed with patented CFV technology.

About MyPurMist

MyPurMist is a Healthcare company based in Concord (United States) founded in 2001. Medical humidification devices are developed with patented CFV technology. MyPurMist has raised $8.89 million across 6 funding rounds from investors including Keiretsu Forum, Band of Angels and RSH Ventures. The company has 5 employees. Its website mypurmist.com draws about 11 thousand monthly visits. MyPurMist offers products and services including Mypurmist 2 Inhaler, Facial Steam Mask, and Refills and Scentpads. Its focus areas include Life Sciences, ENT Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Vapore, LLC. Its competitors include Intersect ENT, Tivic Health and Acclarent; 3 of its 3 listed competitors have raised funding.

Company details

MyPurMist was founded in 2001 and is based in Concord, United States. Operations focus on the medical devices sector, where humidification technology is advanced through the patented Capillary Force Vaporizer (CFV) method. The flagship product, MyPurMist, generates steam vapor for delivery into sinuses, mouth, throat, and lungs. This approach addresses congestion, allergies, and related discomfort in respiratory care applications.

  • Headquarters Concord, United States
  • Employees 5
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mypurmist.com
  • Social LinkedIn X Facebook
  • Legal Name Vapore, Llc
Operational Areas
Key Metrics
  • Total Equity Funding
    $8.89M (USD)

    in 6 rounds

  • Latest Funding Round
    $982.27K (USD), Seed

    Apr 2016

  • Investors
  • Employee Count
    5

Products & Services of MyPurMist

MyPurMist offers a comprehensive portfolio of products and services, including Mypurmist 2 Inhaler, Facial Steam Mask, and Refills and Scentpads.

Mypurmist 2 Inhaler
Steam Inhaler

Handheld device for natural relief from sinus and respiratory issues

Facial Steam Mask
Skin Care Accessory

Accessory for hydrating skin and unclogging pores via steam

Refills and Scentpads
Accessory Kit

Consumables for enhancing inhaler functionality and aromatherapy

Funding Insights of MyPurMist

MyPurMist has successfully raised a total of $8.89M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $982.27 thousand completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.89M
  • Total Rounds 6
  • Last Round Seed β€” $982,272
  • First Round $2.5M

    (Sep 2009)

  • Investors Count 3

All 6 funding rounds of MyPurMist with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2016$982,272Seed––
–
Dec 2013$1.12MSeed––
–
Nov 2012$2.5MSeed––
–
Nov 2010$1.1MSeed––
–
Jun 2010$686,873Seed––
–
Sep 2009$2.5MSeed––
Valuation history

3 investors in total: 3 institutional.

Investors in MyPurMist

MyPurMist has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Keiretsu Forum, Band of Angels and RSH Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Angel investing in high-tech and life science startups since 1994.
bandangels.com
Accredited investors are networked for private equity funding opportunities.
2000keiretsuforum.comSan Francisco, United States
rshventures.tcc.mode
Premium access

Investor details for MyPurMist

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MyPurMist

3 dated milestones of MyPurMist across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded MyPurMist is founded.
  2. Funding First funding round of $2.5M.
  3. Funding Latest funding round, Seed, of $982K.

Competitors of MyPurMist

MyPurMist has 3 listed competitors in our database, 3 of them funded. They include Intersect ENT, Tivic Health and Acclarent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
intersectent.com2003Menlo Park, United States$76.53M371
Drug-releasing implants for sinusitis treatment are developed.
tivichealth.com2016Menlo Park, United States$8M16
Bioelectronic devices for sinusitis pain relief are developed.
acclarent.com2004Irvine, United States$61M349
Balloon-based sinuplasty technologies are developed for ENT surgeons.
Premium access

Detailed competitors of MyPurMist

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MyPurMist

The website of MyPurMist (mypurmist.com) receives about 10.9K visits a month.

  • Monthly visits
    10.9K

    ▼ 58.6% vs previous month

Similar websites

Websites whose visitors overlap most with MyPurMist. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nysinuscenter.com
nysinuscenter.com
100%
#9,820,584–
sinupulse.com
sinupulse.com
100%
#2,312,109–
maxairnosecones.com
99%
11.3K#1,885,157View details
mysinustory.com
mysinustory.com
53%
–
josephbjacobs.com
josephbjacobs.com
52%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for MyPurMist

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in ENT Disorders

3 companies that operate in the same segment as MyPurMist (ENT Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medicines are developed to protect, repair, and restore hearing capacity.
2015Cambridge, Massachusetts, United StatesUSD 169.53 M62
Small molecule therapeutics for ENT diseases are developed.
2005Watertown, United StatesUSD 127.61 MUSD 1.53 M30
Hearing aids are supplied for individuals with hearing disabilities.
2010San Jose, California, United StatesUSD 216.58 M45
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MyPurMist

MyPurMist was founded in 2001 and raised its 1st funding round 8 years after it was founded.

MyPurMist is headquartered in Concord, United States. It is registered at Concord, New Hampshire, United States.

MyPurMist is a funded company, having raised a total of $8.89M across 6 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on Sep 2009.

MyPurMist has 5 employees.

MyPurMist was founded in 2001 and is based in Concord, United States. Operations focus on the medical devices sector, where humidification technology is advanced through the patented Capillary Force Vaporizer (CFV) method. The flagship product, MyPurMist, generates steam vapor for delivery into sinuses, mouth, throat, and lungs. This approach addresses congestion, allergies, and related discomfort in respiratory care applications.

MyPurMist's top competitors include Tivic Health, Intersect ENT and Acclarent.

MyPurMist offers Mypurmist 2 Inhaler, Facial Steam Mask, and Refills and Scentpads.

MyPurMist has 3 investors. Key investors include Keiretsu Forum, Band of Angels, and RSH Ventures.

MyPurMist operates through Vapore, Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available